Persius/hicric huggingface dataset:
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
  
   
The rules state that sacral nerve stimulation is covered for the treatment of urinary urge incontinence, urgency-
frequency syndrome, and urinary retention. Sacral nerve stimulation involves both a temporary test stimulation 
to determine if an implantable stimulator would be effective and a permanent implantation in appropriate 
candidates. Both the test and the permanent implantation are covered. 
 
The following limitations for coverage apply to all three indications: 
Patient must be refractory to conventional therapy (documented behavioral, pharmacologic and/or surgical 
corrective therapy) and be an appropriate surgical candidate such that implantation with anesthesia can occur. 
 
Patients with stress incontinence, urinary obstruction, and specific neurologic diseases (e.g., diabetes with 
peripheral nerve involvement) which are associated with secondary manifestations of the above three 
indications are excluded. 
 
Patient must have had a successful test stimulation in order to support subsequent implantation. Before a 
patient is eligible for permanent implantation, he/she must demonstrate a 50% or greater improvement through 
test stimulation. Improvement is measured through voiding diaries. 
 
Patient must be able to demonstrate adequate ability to record voiding diary data such that clinical results of the 
implant procedure can be properly evaluated. 
 
You can find this information in the National Coverage Determination (NCD) - Sacral Nerve Stimulation For 
Urinary Incontinence (230.18). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that Medicare makes payment for an assistant at surgery when the procedure is authorized for an 
assistant and the person performing the service is a physician, physician assistant (PA), nurse practitioner (NP) 
or a clinical nurse specialist (CNS). You can find this information in the Medicare Claims Processing Manual 
Chapter 4, Section 250.9.1. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that Medicare will not pay for dental services. Dental services are items and services involving 
the care, treatment, filling, removal or replacement of teeth or structures directly supporting the teeth. Medicare 
defines "structures directly supporting the teeth" as the periodontium, which includes the gingivae, 
dentogingival junction, periodontal membrane, cementum of the teeth, and alveolar process. You can find this 
rule in the Social Security Act, Section 1862(a)(12) and in the Centers for Medicare and Medicaid Services, 
Internet Only Manual, Publication 100-02, Medicare Benefit Policy Manual, Chapter 15, Section 150. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The contract 
says that the Plan covers certain dental services as a supplemental (extra) benefit. This benefit does not include 
coverage for dental service codes D6065 or D6056. You can find this information in Chapter 4 on page 84 of 
the Plans 2023 Evidence of Coverage (EOC).
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that Medicare has a non-coverage policy for all platelet rich plasma injections and/or 
applications as a means of managing musculoskeletal injuries and/or joint conditions. You can find this rule in 
Local Coverage Determination (LCD) Platelet Rich Plasma (L38937). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say a health plan must disclose to its enrollees in clear, accurate terms all cost sharing information 
(such as copayments, deductibles and coinsurance). You can find this rule at 42 CFR Section 422.111(a) and 
(b). 
 
The rules say that a copayment is a fixed amount charged to an enrollee on a per-service basis. The rules say 
that coinsurance is a fixed percentage of the total amount paid for a health care service that can be charged to 
an enrollee on a per-service basis. You can find this rule at 42 CFR Section 422.2. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The Plan 
contract says that enrollees must pay 20% coinsurance for in-network Medicare Part B drugs. You can find this 
information on pages 98-99 of the Plan's 2022 Evidence of Coverage (EOC).  
 
The Plan contract also says that enrollees must pay a $325 copayment for each in-network outpatient surgery. 
You can find this information on pages 106-107 of the Plans 2022 EOC.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that Medicare will pay for durable medical equipment that is mainly used to serve a medical 
purpose. Items such as hospital beds, respirators, wheelchairs and crutches are examples of equipment that are 
clearly used for medical purposes. Medicare will not pay for equipment that is primarily and customarily used 
for nonmedical purposes or equipment used for a patients comfort or for the convenience of a person caring 
for the patient. You can find these rules in the Centers for Medicare and Medicaid Services, Internet Only 
Manual, Publication 100-02, Medicare Benefit Policy Manual, Chapter 15, Section 110.1. 
 
The rules say that a seat lift mechanism is covered if all of the following are met: 
 
1. The enrollee must have severe arthritis of the hip or knee or have a severe neuromuscular disease.  
2. The seat lift mechanism must be a part of the treating practitioner's course of treatment and be prescribed to 
improve, or stop deterioration of, the enrollee's condition. 
3. The enrollee must be completely unable to stand up from a regular armchair or any chair in the home.  
4. Once standing, the enrollee must have the ability to walk. 
 
You can find this information in the Local Coverage Determination and Article for Seat Lift Mechanisms 
(L33801 and A52518). 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that Effective for dates of service on or after January 1, 2018, the KX modifier continues to be 
used. It no longer represents an exception request but serves as a confirmation that services are medically 
necessary after the beneficiary has exceeded the KX modifier threshold of incurred expenses. Medicare claims 
systems process claims with and without the KX modifier in the same manner described below and in section 
10.4. 
 
When exceptions are in effect and the beneficiary qualifies for a therapy cap exception, the provider shall add a 
KX modifier to the therapy HCPCS code subject to the cap limits. The KX modifier shall not be added to any 
line of service that is not a medically necessary service; this applies to services that, according to a local 
coverage determination by the contractor, are not medically necessary services. 
 
The GN, GO, or GP therapy modifiers are currently required to be appended to therapy services. 
In addition to the KX modifier, the GN, GP and GO modifiers shall continue to be used. 
 
You can find these rules in the Centers for Medicare & Medicaid Services, Medicare Claims Processing 
Manual Chapter 5, Section 10.3.3. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that the administration of continuous subcutaneous insulin for the treatment of diabetes mellitus 
if criterion A or B is met and if criterion C or D is met: 
A. C-peptide testing requirement  must meet criterion 1 or 2 and criterion 3: 
 
1. C-peptide level is less than or equal to 110 percent of the lower limit of normal of the 
laboratory's measurement method. 
2. For beneficiaries with renal insufficiency and a creatinine clearance (actual or calculated from 
age, weight, and serum creatinine) less than or equal to 50 ml/minute, a fasting C-peptide level 
is less than or equal to 200 per cent of the lower limit of normal of the laboratorys measurement 
method. 
3. A fasting blood sugar obtained at the same time as the C-peptide level is less than or equal to 
225 mg/dl. 
B. Beta cell autoantibody test is positive. 
C. The beneficiary has completed a comprehensive diabetes education program, has been on a program of 
multiple daily injections of insulin (i.e., at least 3 injections per day) with frequent self-adjustments of 
insulin dose for at least 6 months prior to initiation of the insulin pump, and has documented frequency 
of glucose self-testing an average of at least 4 times per day during the 2 months prior to initiation of 
the insulin pump, and meets one or more of the following criteria (1 - 5) while on the multiple injection 
regimen: 
1. Glycosylated hemoglobin level (HbA1C) greater than 7 percent 
2. History of recurring hypoglycemia 
3. Wide fluctuations in blood glucose before mealtime 
4. Dawn phenomenon with fasting blood sugars frequently exceeding 200 mg/dL 
5. History of severe glycemic excursions 
D. The beneficiary has been on an external insulin infusion pump prior to enrollment in Medicare and has 
documented frequency of glucose self-testing an average of at least 4 times per day during the month 
prior to Medicare enrollment. 
 
 If criterion A or B is not met, the pump and related accessories, supplies, and insulin will be denied as not 
reasonable and necessary. If criterion C or D is not met, the pump and related accessories, supplies, and insulin 
will be denied as not reasonable and necessary. You can find this rule in the Local Coverage Determination for 
External Infusion Pumps, L33794.  
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that a test panel is a single test with multiple components and is characterized by a single unit of 
service (UOS =1). A panel cannot be unbundled and billed as individual components regardless of the fact that 
the test reports multiple individual pathogens and/or targets. You can find this information in the Centers for 
Medicare and Medicaid Services, Local Coverage Article (LCA): Billing and Coding: Respiratory Pathogen 
Panel Testing (A58577). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that Medicare Advantage plans may specify brands and manufacturers as preferred and charge 
lower cost-sharing for the preferred brands or may limit the DME to only those preferred brands and 
manufacturers, as long as certain conditions are met. You can find this rule in the Centers for Medicare and 
Medicaid Services, Internet Only Manual, Publication 100-16, Medicare Managed Care Manual, Chapter 4, 
Section 10.12.2. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The Plan 
contract says that Abbott and Lifescan glucometers, diabetic test strips, lancets, control solutions, and a 
continuous glucose monitoring device are available for dispense via a retail or mail order pharmacy. All other 
desired brands will need to be obtained from a durable medical equipment supplier, or via an exception 
process. You can find this information on pages 53-54 of the Plan's 2023 Evidence of Coverage.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that Medicare covers percutaneous left atrial appendage closure (LAAC) for non-valvular atrial 
fibrillation (NVAF) through Coverage with Evidence Development (CED). The patient must have: 
- A CHADS2 score 2 or greater (Congestive heart failure, Hypertension, Age greater than 75, Diabetes, 
Stroke/transient ischemia attack/thromboembolism) or CHA2DS2-VASc score 3 or greater (Congestive 
heart failure, Hypertension, Age 65 or more, Diabetes, Stroke/transient ischemia 
attack/thromboembolism, Vascular disease, Sex category) 
- A formal shared decision making interaction with an independent non-interventional physician using an 
evidence-based decision tool on oral anticoagulation in patients with NVAF prior to LAAC. 
Additionally, the shared decision making interaction must be documented in the medical record. 
- A suitability for short-term warfarin but deemed unable to take long-term oral anticoagulation following 
the conclusion of shared decision making, as LAAC is only covered as a second line therapy to oral 
anticoagulants. The patient (preoperatively and postoperatively) is under the care of a cohesive, 
multidisciplinary team (MDT) of medical professionals. The procedure must be furnished in a hospital 
with an established structural heart disease (SHD) and/or electrophysiology (EP) program. 
 
You can find these rules in National Coverage Determination (NCD) Percutaneous Left Atrial Appendage 
Closure (LAAC) (20.34). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that Telephone Alert Systems are not covered because emergency communications systems do 
not serve a diagnostic or therapeutic purpose. You can find this information in Medicare's National Coverage 
Determination (NCD) for Durable Medical Equipment Reference List (280.1). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that providers/suppliers must report services correctly. Procedures should be reported with the 
Current Procedural Terminology (CPT) code that describes the services performed. You can find this rule in 
the Centers for Medicare and Medicaid Services, Medicare National Correct Coding Initiative Policy Manual 
for Medicare Services, Chapter I(A). 
 
The rules say that molecular diagnostic laboratory tests must undergo an application and technical assessment 
process through the Molecular Diagnostics (MolDX) contractor. MolDX will review all new test/assay clinical 
information to determine if a test meets Medicares reasonable and necessary requirement. Labs must submit a 
comprehensive dossier on each new test/assay prior to claim submission. MolDX will only cover and 
reimburse tests that demonstrate analytical and clinical validity, and clinical utility at a level that meets the 
Medicare reasonable and necessary requirement. This rule requires that all tests that are approved by this 
process be assigned a unique test identifier from the DEXTM Diagnostics Exchange. Only approved tests will be 
reimbursed consistent with the effective date of the coverage determination. This unique identifier must be 
reported on the claim. You can find this rule in the Local Coverage Determination (LCD): MolDX: Molecular 
Diagnostic Tests (MDT), L35025, and the related Local Coverage Article: Billing and Coding: MolDX: 
Molecular Diagnostic Tests (MDT), A56853. 
 
The rules say that the Physician Fee Schedule Status Indicator B means that payment for covered services is 
always bundled into payment for other services not specified. There will be no payment amounts for these 
codes and no separate payment is ever made. When these services are covered, payment for them is subsumed 
by the payment for the services to which they are incident. You can find this information in the Centers for 
Medicare and Medicaid Services, Internet Only Manual, Publication 100-04, Medicare Claims Processing 
Manual, Chapter 23, 30.2.2. 
 The rules say that the Physician Fee Schedule Status Indicator T means that there are payment amounts for 
these services, but they are only paid if there are no other services payable under the physician fee schedule 
billed on the same date by the same provider. If any other services payable under the physician fee schedule are 
billed on the same date by the same provider, these services are bundled into the physician services for which 
payment is made. You can find this information in the Centers for Medicare and Medicaid Services, Internet 
Only Manual, Publication 100-04, Medicare Claims Processing Manual, Chapter 23, 30.2.2. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
  
  The rules say that molecular diagnostic laboratory tests must undergo an application and technical assessment 
process through the Molecular Diagnostics (MolDX) contractor. MolDX will review all new test/assay clinical 
information to determine if a test meets Medicares reasonable and necessary requirement. Labs must submit a 
comprehensive dossier on each new test/assay prior to claim submission. MolDX will only cover and 
reimburse tests that demonstrate analytical and clinical validity, and clinical utility at a level that meets the 
Medicare reasonable and necessary requirement. This rule requires that all tests that are approved by this 
process be assigned a unique test identifier from the DEXTM Diagnostics Exchange. Only approved tests will be 
reimbursed consistent with the effective date of the coverage determination. This unique identifier must be 
reported on the claim. You can find this rule in the Local Coverage Determination (LCD): MolDX: Molecular 
Diagnostic Tests (MDT) (L36807) and the related Local Coverage Article: Billing and Coding: MolDX: 
Molecular Diagnostic Tests (MDT) (A57772). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that Medicare does not separately reimburse for repairs of: 
 
- Items in the frequent and substantial servicing payment category; or, 
- Oxygen equipment; or, 
- Items in the capped rental payment category during the capped rental period; or, 
- Items covered under a manufacturers or suppliers warranty; or, 
- Previously denied items. 
 
You can find this information in the Local Coverage Article: Standard Documentation Requirements for All 
Claims Submitted to DME MACs (A55426). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that only a minority of beneficiaries who undergo debridements for wound care appear to 
require more than eight total surgical excisional debridement services involving subcutaneous tissue, 
muscle/fascia, or bone in a 360 day period, (five debridements of which involve removal of muscle/fascia, 
and/or bone) in order to accomplish the desired objective of the treatment plan of the wound. Only when 
medical necessity continues to be met and there is documented evidence of clear benefit from the debridements 
already provided, should debridement services be continued beyond this frequency or time frame. You can find 
this rule in the Local Coverage Determination (LCD) for Wound Care (L35125). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.